quinacrine has been researched along with tilorone in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (47.06) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Chiang, GH; Unger, SH | 1 |
| Denny, WA; Feigon, J; Kearns, DR; Leupin, W | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T | 1 |
| Byun, SY; Choi, I; Jeon, S; Kim, S; Ko, M; Lee, J; Park, S; Shum, D | 1 |
| Ekins, S; Lane, TR | 1 |
| Mannering, GJ; Renton, KW | 1 |
| Ciak, J; Hahn, FE | 1 |
| Bogdanovsky, D; Pierre, M | 1 |
| Degré, M; Gláz, ET | 1 |
| Creuzet, C; Loeb, JE | 1 |
| Gláz, ET; Tálas, M | 1 |
| Lüllmann-Rauch, R; Pods, R; von Witzendorff, B | 1 |
| Avrahami, D; Friedman-Levi, Y; Gabizon, R; Mayer-Sonnenfeld, T | 1 |
| Comer, JE; Ekins, S; Freiberg, AN; Lane, TR; Madrid, PB | 1 |
| Dyall, J; Ekins, S; Foil, DH; Goodin, C; Holbrook, MR; Lane, TR; Liang, JY; Madrid, PB; Mercer, L; Postnikova, E; Zhou, H | 1 |
17 other study(ies) available for quinacrine and tilorone
| Article | Year |
|---|---|
Octanol-physiological buffer distribution coefficients of lipophilic amines by reversed-phase high-performance liquid chromatography and their correlation with biological activity.
Topics: Amines; Animals; Buffers; Chromatography, High Pressure Liquid; Histamine Release; Lipid Metabolism; Octanols; Protein Binding; Rats; Serum Albumin, Bovine; Sodium-Potassium-Exchanging ATPase; Solubility; Structure-Activity Relationship | 1981 |
Interactions of antitumor drugs with natural DNA: 1H NMR study of binding mode and kinetics.
Topics: Antineoplastic Agents; Base Composition; Chemical Phenomena; Chemistry; DNA; Hydrogen Bonding; Intercalating Agents; Kinetics; Magnetic Resonance Spectroscopy; Structure-Activity Relationship | 1984 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets.
Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics | 2012 |
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Niclosamide; Pandemics; Pneumonia, Viral; Pregnenediones; SARS-CoV-2; Vero Cells | 2020 |
Toward the Target: Tilorone, Quinacrine, and Pyronaridine Bind to Ebola Virus Glycoprotein.
Topics: | 2020 |
Depression of hepatic cytochrome P-450-dependent monooxygenase systems with administered interferon inducing agents.
Topics: Animals; Cytochrome P-450 Enzyme System; Interferons; Male; Mengovirus; Microsomes, Liver; Oxygenases; Pertussis Vaccine; Poly I-C; Quinacrine; Rats; RNA; Tilorone | 1976 |
Bactericidal effects of combinations of ampicillin with anti-R-plasmid compounds on Salmonella typhimurium R1+.
Topics: Acridines; Ampicillin; Drug Combinations; Ethidium; Quinacrine; R Factors; Salmonella typhimurium; Tilorone | 1977 |
Effect of tilorone and quinacrine on translation in reticulocyte lysates.
Topics: Animals; Fluorenes; Hemin; Leucine; Phenylhydrazines; Protein Biosynthesis; Quinacrine; Rabbits; Reticulocytes; Tilorone | 1979 |
Interferon induction in human cell cultures by small molecular inducers (tilorone and acridines).
Topics: Acridines; Cells, Cultured; Fibroblasts; Fluorenes; Humans; Interferon Inducers; Interferons; Leukocytes; Molecular Weight; Quinacrine; Tilorone | 1977 |
Action of hemin on chromatin protein kinases of rat liver.
Topics: Animals; Caseins; Chromatin; Heme; Hemin; In Vitro Techniques; Liver; Male; Phosvitin; Protein Kinase Inhibitors; Protein Kinases; Quinacrine; Rats; Tilorone | 1977 |
Comparison of the ability of small molecular interferon inducers: tilorone and acridine drugs.
Topics: Acridines; Aminacrine; Animals; Body Temperature; Chick Embryo; Chickens; Culture Techniques; Cycloheximide; Dactinomycin; Female; Fluorenes; Interferon Inducers; Interferons; Male; Mice; Propanolamines; Quinacrine; Rabbits; Tilorone; Vaccinia virus | 1975 |
The antimalarials quinacrine and chloroquine induce weak lysosomal storage of sulphated glycosaminoglycans in cell culture and in vivo.
Topics: Animals; Anti-Inflammatory Agents; Antimalarials; beta-N-Acetylhexosaminidases; Cattle; Cells, Cultured; Chloroquine; Dose-Response Relationship, Drug; Female; Fibroblasts; Glycosaminoglycans; Histocytochemistry; Lipidoses; Liver; Lysosomes; Microscopy, Electron; Microscopy, Fluorescence; Mucopolysaccharidoses; Quinacrine; Rats; Rats, Wistar; Structure-Activity Relationship; Sulfates; Tilorone | 1996 |
Chemically induced accumulation of GAGs delays PrP(Sc) clearance but prolongs prion disease incubation time.
Topics: Animals; Antiviral Agents; Central Nervous System; CHO Cells; Cricetinae; Cricetulus; Enzyme Inhibitors; Glycosaminoglycans; Infectious Disease Incubation Period; Lysosomes; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Neurons; Prion Diseases; Protein Conformation; PrPSc Proteins; Quinacrine; Subcellular Fractions; Tilorone; Time Factors | 2008 |
Repurposing Quinacrine against Ebola Virus Infection
Topics: Animals; Antimalarials; Antiviral Agents; Caco-2 Cells; Chlorocebus aethiops; Disease Models, Animal; Drug Repositioning; Ebolavirus; HeLa Cells; Hemorrhagic Fever, Ebola; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Quinacrine; Survival Analysis; Tilorone; Vero Cells; Viral Load | 2019 |
Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease.
Topics: Antiviral Agents; Artesunate; Drug Combinations; Drug Repositioning; Drug Synergism; Ebolavirus; HeLa Cells; Hemorrhagic Fever, Ebola; Humans; Lysosomes; Machine Learning; MCF-7 Cells; Naphthyridines; Quinacrine; Tilorone; Virus Internalization | 2020 |